Securities code: 002589 securities abbreviation: Realcan Pharmaceutical Group Co.Ltd(002589) Announcement No.: 2022-010 Realcan Pharmaceutical Group Co.Ltd(002589)
Announcement on guarantee provided by wholly-owned subsidiaries for listed companies
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. 1、 Overview of guarantee
Realcan Pharmaceutical Group Co.Ltd(002589) (hereinafter referred to as “the company”) held the 10th meeting of the Fourth Board of directors on December 11, 2020, deliberated and adopted the proposal on the adjustment of the comprehensive credit line applied by the company and its wholly-owned subsidiaries to financial institutions, and agreed that the company and its wholly-owned subsidiaries apply to the bank for a comprehensive credit line with a total amount of no more than 15 billion yuan. For details, please refer to China Securities Journal, securities times, Securities Daily, Shanghai Securities News and cninfo.com on December 12, 2020（ http://www.cn.info.com.cn. ）Announcement on the resolution of the 10th meeting of the Fourth Board of directors (Announcement No.: 2020-077).
According to the needs of the company’s operation and development, the company applies for a comprehensive credit line of no more than RMB 1.05 billion from the banks in the following list. The company’s wholly-owned subsidiaries Realcan Pharmaceutical Group Co.Ltd(002589) (Shandong) Co., Ltd. (hereinafter referred to as “Ruikang Shandong”) and Zibo Ruikang Drug Distribution Co., Ltd. (hereinafter referred to as “Zibo Ruikang”) provide joint and several liability guarantee for the above financing matters of the company.
Company name bank name credit line term
(RMB 10000)
China Zheshang Bank Co.Ltd(601916) limited liability company 75000.00 not exceeding 3 years
Division Jinan Branch
Bank Of Qingdao Co.Ltd(002948) Co., Ltd
Ruikang Shandong division Yantai Development Zone Science and technology branch 5000.00, no more than 3 years
that ‘s ok
Qilu Bank Co.Ltd(601665) Co., Ltd. 10000.00 not more than 3 years
Division Yantai Branch
Zibo Ruikang Rizhao Bank Co., Ltd. 15000.00 not more than 3 years
Division Yantai Branch
According to the relevant provisions of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, the above guarantee matters have been subject to the internal approval procedures of Ruikang Shandong and Zibo Ruikang, and do not need to be submitted to the board of directors and the general meeting of shareholders for deliberation.
2、 Basic information of the guaranteed 1. Name of the guaranteed: Realcan Pharmaceutical Group Co.Ltd(002589) 2. Unified social credit Code: 91370000766690447b3. Type: other joint stock limited companies (listed)
4. Date of establishment: September 21, 2004
5. Business term: September 21, 2004 to
6. Address: No. 326, Jichang Road, Zhifu District, Yantai City 7. Legal representative: Han Xu 8. Registered capital: 1504.717 million yuan 9. Business scope: Traditional Chinese medicine, decoction pieces of traditional Chinese medicine, proprietary Chinese medicine, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products (except vaccines), psychotropic drugs, narcotic drugs, protein assimilation preparations, peptide hormones Wholesale of toxic drugs, poppy shells and pharmaceutical precursor chemicals for medical use; Wholesale and retail of class I, II and III medical devices; Sales of prepackaged food (including refrigerated and frozen food), infant formula milk powder, other infant formula food, health food and formula food for special medical purposes; Sales of daily necessities, fitness equipment, cosmetics and disinfectants; Storage and distribution of drugs; General freight; Special transportation of goods (refrigeration and preservation); Production, processing, leasing, sales, washing and distribution of medical fabrics; Wholesale of glassware, chemical products (excluding hazardous chemicals) and chemical reagents (excluding hazardous chemicals); Medical device leasing and technical services; Warehousing services (except for special national regulations); Economic and trade consultation; Sales of electronic products; Medical equipment maintenance; Chinese herbal medicine processing; Import and export of goods and technology. (excluding projects restricted and prohibited by the state; projects that must be approved according to law can only be carried out after being approved by relevant departments) 10. Equity structure and related relationship: Ruikang Shandong and Zibo Ruikang are wholly-owned subsidiaries of the company, and the company holds 100% equity of Ruikang Shandong and Zibo Ruikang. 11. The financial data of the company in the latest year and period are as follows:
Unit: 10000 yuan
The third quarter of 2021 and the year of 2020
(Unaudited) (audited)
Total assets 2886514.09 3129019.43
Total liabilities 1880151.72 2081045.53
Net assets 1006362.37 1047973.9
Operating income 1763570.77 2720388.39
Total profit 53725.85 91547.86
Net profit 38943.00 62455.18
12. Contingencies: none 13. The company is not a dishonest person.
3、 The impact of the guarantee provided by the wholly-owned subsidiary on the company
The above guarantees have been subject to the corresponding internal approval procedures. The wholly-owned subsidiary provides guarantees for the company, and the risk is controllable, which is conducive to improving the company’s financing ability, ensuring the company’s normal working capital needs, meeting the company’s business development needs, and in line with the company’s overall interests. The guarantee complies with relevant regulations, the decision-making procedure is legal and effective, and there is no situation that damages the interests of the company and all shareholders, especially minority shareholders. 4、 Accumulated external guarantees and overdue guarantees
As of the disclosure date of this announcement, the company’s actual guarantee balance was 3048.8139 million yuan, accounting for 40.81% of the company’s latest audited net assets attributable to the parent company. The company’s external guarantee is to provide guarantee for subsidiaries within the scope of consolidated statements, mutual guarantee between subsidiaries, and there is no other external guarantee. The company and its subsidiaries have no overdue external guarantees, guarantees involving litigation and losses due to the judgment of losing the guarantee. 5、 Documents for future reference 1. Decisions of shareholders of Realcan Pharmaceutical Group Co.Ltd(002589) (Shandong) Co., Ltd; 2. Decided by the shareholders of Zibo Ruikang Pharmaceutical Distribution Co., Ltd; It is hereby announced.
Realcan Pharmaceutical Group Co.Ltd(002589) board of directors
January 24, 2022
